Title: Global & China Graphene Industry Trends and Growth Analysis to 2015
1Research on Global China Graphene Industry,
2015
Single User
License US 1700 No of Pages 86
Corporate User
License US 2750
- www.rnrmarketresearch.com
WEBSITE
2Research on China Heparin Industry, 2015
- In-depth analysis of Graphene Industry in Global
China, 2015 Report. Currently graphene is
still in the research stage. The limitations of
preparative technique and the inactive downstream
demand determined that the graphene has yet to
achieve large-scale mass production. - In 2014, electronics, optoelectronics and data
storage accounts for nearly 31 of global gaphene
demand, composites ranks behind with a share of
nearly 24. - View Complete Report _at_ http//www.rnrmarketresearc
h.com/research-on-global-china-graphene-industry-2
015-market-report.html
3Research on China Heparin Industry, 2015
- The market size of Chinas graphene market is
about 29 million RMB, and could achieve a CAGR of
95 from 2014 to 2020. The driving forces mainly
comes from composites and touch screen market. - In 2014, graphene composites markets in China
achieves 4.77 million RMB sales, accounting for
16.4 of total graphene sales in China. - Purchase a Copy of this Report _at_
http//www.rnrmarketresearch.com/contacts/purchase
?rname392988
4Research on China Heparin Industry, 2015
- In May 2015, Qianhong Bio-Pharma received the
approval letter of enoxaparin sodium API and
injection from CFDA. This made Qianhong the 5th
enterprises for producing enoxaparin sodium in
domestic market. (Time to volume production is
still uncertain). - In 2014, GSK, Changshan Biochemical
Pharmaceutical and Hefei Zhaoke were top3
enterprises in the domestic low molecular heparin
calcium market, with total market share of 88.7
in 2014. GSK is the leading enterprises in this
segment for a long time, but its growth has
slowed down in recent 2 to 3 years. Changshans
product achieved rapid development relying on
independent pricing, which is gradually becoming
the import substitution product. - In May 2015, Qianhong Bio-Pharma received the
approval letter of enoxaparin sodium API and
injection from CFDA. This made Qianhong the 5th
enterprises for producing enoxaparin sodium in
domestic market. (Time to volume production is
still uncertain). - Access Report by Chisult Insight at
http//www.rnrmarketresearch.com/publisher/Chisult
-Insight.html -
-
-
5Research on China Heparin Industry, 2015
- Data Charts
- Hierarchical Structure of GrapheneProperties
Applications of GrapheneSketch map of wireless
transmission ballistic transistorConductivity of
Major Conductors(S/m)Carrier Mobility of Major
Semiconductors(cm2/Vs)Enhanced Effect
Comparison of Nano-fillerThermal Conductivity of
Major Heat Sink materialsGraphene Absorbing
BTEXFour PreparationTechnologies of
GrapheneEach application requires a specific
type and grade of graphene2013-2014 Graphite
Output and Reserves Worldwide by CountriesMajor
Graphene Device Processors WorldwideRead
moreInquire for Discount _at_ http//www.rnrmarketre
search.com/contacts/discount?rname392988 -
6RnR Market ResearchRnRMarketResearch.com, An
online repository of market research reports,
offers in-depth analysis of over 5000 market
segments. RNR market research library has
syndicated reports by leading market research
publishers across the globe. For more details
contact sales_at_rnrmarketresearch.Com /
18883915441FOLLOW US
Website
www.rnrmarketresearch.com